Search PeptideClear
Peptides, vetted UK sellers, or GLP-1 clinics. Pick a tab below.
Try a quick search
We have not vetted that site yet.
PeptideClear can audit this source for you for free. Editorial verdict within 72 hours.
Got it. Editorial verdict within 72 hours.
We will email you a link to the published /retailer/[slug]/ profile once the audit lands.
While you wait, 3 already-vetted alternatives
Alternatives are matched to your stated goal. We earn nothing if you click through, and the links carry no tracking. How we are funded.
UK GLP-1 landscape · 2026
Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)
Last reviewed: 2026-07-19
The UK GLP-1 weight-loss landscape has five practical routes, not one. NHS specialist-led services cover narrow eligibility cohorts under Tier 3 and Tier 4 referral. Private high-touch clinics bundle the medication with a coach and app. UK online pharmacies dispense the same medication against a questionnaire. Walk-in private pharmacy and GP-referral-to-private routes round out the picture. The right route depends on eligibility, support needs, and budget. PeptideClear is a comparison and information service. We compare on price and evidence. We do not sell, prescribe, or take payment for placement.
Compare UK GLP-1 clinicsThe UK GLP-1 weight-loss landscape splits across five routes. NHS specialist-led Tier 3 and Tier 4 services cover tightly defined cohorts and need GP referral. Private high-touch clinics (Numan, Voy, Manual, Juniper) bundle medication with coach and app from around £189 to £349 per month. UK online pharmacies (Phlo, Pharmacy2U, SimplyMeds, Boots Online Doctor, Asda Online Doctor) dispense via questionnaire at the cheaper end. Walk-in private pharmacy and GP-referral-to-private fill the in-person niche. The right route depends on eligibility, support, and budget. Your prescriber decides which medication and dose is appropriate for your individual circumstances.
Each route uses the same regulator backbone (GPhC for the pharmacy, GMC for the prescriber) but differs in how the consultation runs, what is bundled, and what it costs.
Free at point of use. Specialist Tier 3 / Tier 4 referral required.
NHS England rolled GLP-1 medication out in phased cohorts through specialist weight-management services. Eligibility is tightly defined and access is via GP referral into a Tier 3 or Tier 4 specialist service, not direct request. Geographic availability varies by ICB.
Subscription. Coach, app, prescriber oversight.
Numan, Voy, Manual, Juniper. The medication plus a structured programme: digital coach, dose progression app, prescriber check-ins, and in some cases blood tests. GPhC pharmacy registration, GMC-registered prescribers throughout.
Per-month dispensing. Questionnaire-only consult.
Phlo, Pharmacy2U, SimplyMeds, Boots Online Doctor, Asda Online Doctor. The same medication, dispensed against an online questionnaire and prescriber review. No structured coaching layer. The maintenance route once a user is stable on dose.
In-person consult. Prescription supplied locally.
Some independent and chain pharmacies offer in-person private weight-management consultations with a pharmacist prescriber. The route is geographically uneven and depends on whether the local branch has a prescribing pharmacist.
Mixed. GP refers, user pays clinic.
A GP may write a referral letter into a private specialist weight-management service. Sometimes used by patients who do not meet NHS cohort criteria but want a face-to-face NHS-style pathway, paid privately.
There is no single best UK GLP-1 route in the way that comparison content sometimes implies. Two licensed UK GLP-1 medications (semaglutide and tirzepatide) are dispensed across NHS and private routes. The medication is the same. What changes between routes is the consultation depth, who picks up the phone if something goes wrong, the cost per month, and how quickly the next dose tier becomes available.
For users who fit a current NHS cohort, the NHS service is generally the right starting point. Once outside those cohorts, the choice becomes private clinic versus pharmacy versus walk-in. The high-touch clinic adds a coach and an app on top of the prescription, suiting users who want structure for the first three to six months. The pharmacy route suits users who have already stabilised and want straightforward maintenance supply at the lower cost band.
We do not publish a ranked "winner" table because the right answer is route-dependent. The clinic comparison page and the pharmacy comparison page each rank within their own category against transparent criteria (GPhC registration, GMC prescribers, consultation model, published starting price).
Per UK ASA and CAP guidance, we do not run branded comparison content that pits named POM medications against each other on efficacy grounds. We do not publish per-clinic Mounjaro price ladders or per-pharmacy Wegovy price tables; pricing varies by dose tier, supply, and prescriber decision and out-of-date numbers cause more harm than they remove. We do not promote compounded GLP-1 or grey-import routes (Turkey, India, unbranded vials), all of which sit outside MHRA oversight and have been the subject of MHRA enforcement seizures in 2026.
What we do publish is the route map, the regulator-checkable trust signals, and the editorial framing for each named operator. The medication choice and dose belong to a GMC-registered prescriber after consultation.
Head-term editorial covering the GLP-1 landscape. Articles publish on a rolling schedule.
Before you buy anywhere
Six checks separate a legitimate UK supply route from an illegal one: the seller is on the GPhC register, the prescriber is on the GMC register, a real prescription is issued, the product is a UK-licensed medicine, the price sits in the registered-pharmacy range, and the site is not selling a prescription medicine under a "research use only" label. The scale is not theoretical. The MHRA reported seizing almost 20 million doses of illegally traded medicines in 2025, including more than 5,000 illegally traded GLP-1 products, and in 2026 the High Court began ordering UK internet providers to block counterfeit semaglutide websites outright.
A legitimate UK online pharmacy appears on the General Pharmaceutical Council register, and the doctor prescribing for you appears on the GMC register. Both registers are free, public and searchable. A seller who is on neither is not a UK pharmacy, whatever the website says.
Search the GPhC registerEvery GLP-1 weight-management medicine licensed in the UK is prescription-only. If a site will sell you one without a consultation and a prescriber, that supply is illegal under the Human Medicines Regulations 2012. There is no exception for a questionnaire that nobody reads.
Human Medicines Regulations 2012Selling a medicine under a research-only label does not take it outside medicines law. Where a product is presented as having medicinal effects, the MHRA treats it as a medicine regardless of how it is labelled. In May 2026 the MHRA made its largest ever seizure of unlicensed weight-loss medicines, recovering around 12,000 doses that included retatrutide, tirzepatide and peptide products.
MHRA, 29 May 2026In February 2026 the MHRA contacted patients who may have been dispensed fake Mounjaro KwikPen 15mg pens, batch D873576, by a registered Birmingham pharmacy. Testing found the pens did contain tirzepatide, but the manufacturing conditions were unknown so sterility could not be confirmed. Register membership lowers your risk. It does not remove it.
MHRA alert, 24 Feb 2026Licensed GLP-1 medicines have a real manufacturing and distribution cost. A price well under what registered UK pharmacies charge is not a bargain that others have missed, it is a signal about what is in the box. Compare against the range on our clinic and pharmacy pages before you buy anywhere.
What UK routes actually costIf you think a site is supplying medicines illegally, or a product you received is counterfeit, the MHRA has a reporting route. If you have had a side effect from any medicine, report it through the Yellow Card scheme. Patients can report directly, and those reports feed the UK safety monitoring system.
Yellow Card schemeSources: MHRA enforcement and safety announcements on gov.uk, the General Pharmaceutical Council register, and the Human Medicines Regulations 2012. Checked 19 Jul 2026 and tracked on our MHRA enforcement tracker. PeptideClear is editorial and does not prescribe, dispense or sell medicines.
PeptideClear is editorial. Nothing here replaces the regulator, and you should not take our word for any of it. These are the official UK destinations where the underlying position is published, free to read and open to anyone.
MHRA
MHRA Products portalThe Summary of Product Characteristics and Patient Information Leaflet for every medicine licensed in the UK. This is the authoritative document for what a medicine is licensed to do.
MHRA
Yellow Card schemeReport a suspected side effect, a defective medicine, or a fake or counterfeit product. Anyone can report, including patients. Reports feed the MHRA safety monitoring system.
General Pharmaceutical Council
GPhC registersCheck whether a pharmacy, pharmacist or pharmacy technician is registered in Great Britain. A legitimate UK online pharmacy will appear here.
General Medical Council
GMC registerCheck whether the doctor prescribing for you is registered and licensed to practise in the UK.
NICE
NICE guidanceThe technology appraisals and clinical guidelines that set who is eligible for NHS-funded treatment in England, including for weight-management medicines.
NHS
NHS weight-management informationThe NHS patient-facing explanation of weight-management treatment and how to access it through the NHS.
Also on PeptideClear
Research peptides
Encyclopedia and UK retailers
If you also care about the research-tier peptide literature, the encyclopedia covers BPC-157, MOTS-c, GHK-Cu, Ipamorelin and others under research-use-only framing.
VisitCollagen
Marine, bovine, vegan compared
If you also care about ingestible collagen, the hub compares UK brands on type, sourcing, kDa and dose per serving.
VisitCosmetic peptides
UK skincare with GHK-Cu, Matrixyl
If you also care about topical peptide skincare, the cosmetic peptides hub compares UK serums and creams on declared INCI position.
VisitPeptideClear is a trading name of Best Business Loans Ltd, registered in England and Wales (company number 16833937). All services, operations and publications under the PeptideClear brand are delivered by Best Business Loans Ltd.
Registered in England and Wales. Company number 16833937. D‑U‑N‑S 234324824. ICO registered, reference ZC151816 (certificate, verify). Registered supplier on the UK Government's Find a Tender Service (FTS). Details publicly available via Companies House and OpenCorporates.
Operates under UK data protection and consumer standards. Aligns with UK GDPR, ISO 27001 and ISO 9001 principles. Working towards Cyber Essentials certification.
Primary domain peptideclear.co.uk. Business ownership, entity and services remain unchanged. Reviewed quarterly.
PeptideClear takes no commission, referral fee or payment from any retailer, clinic or pharmacy it writes about. Outbound links carry no tracking and earn us nothing. How we are funded.